Jones Financial Companies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.7K Sell
9,379
-1,119
-11% -$7.45K ﹤0.01% 2943
2026
Q1
$54K Buy
10,498
+1,232
+13% +$6.91K ﹤0.01% 2930
2025
Q4
$64.9K Buy
9,266
+2,271
+32% +$17.8K ﹤0.01% 2412
2025
Q3
$57.1K Sell
6,995
-567
-7% -$4.42K ﹤0.01% 2324
2025
Q2
$63.6K Sell
7,562
-3,483
-32% -$25.2K ﹤0.01% 2134
2025
Q1
$89.4K Sell
11,045
-747
-6% -$7.56K ﹤0.01% 1822
2024
Q4
$107K Buy
11,792
+2,079
+21% +$20.1K ﹤0.01% 1601
2024
Q3
$82.2K Buy
9,713
+6,219
+178% +$51.5K ﹤0.01% 1464
2024
Q2
$34.2K Buy
3,494
+3,451
+8,026% +$42.1K ﹤0.01% 1384
2024
Q1
$649 Buy
+43
New +$780 ﹤0.01% 1327
2023
Q1
– Sell
-38
Closed -$1K – 766
2022
Q4
$1K Buy
+38
New +$1.02K ﹤0.01% 709

Other funds holding TDOC

Jones Financial Companies's TDOC Position: Q2 2026 in Review

Jones Financial Companies reduced its Teladoc Health (TDOC) stake by 11% in Q2 2026, selling an estimated $7.45K and leaving 9,379 shares worth $78.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Jones Financial Companies first reported a position in TDOC in Q4 2022 and has held it in 11 quarters since. The position peaked at $107K in Q4 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Jones Financial Companies held 9,379 shares of Teladoc Health worth $78.7K as of Q2 2026.
  • Jones Financial Companies sold 1,119 Teladoc Health shares in Q2 2026, an estimated $7.45K.
  • Teladoc Health made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2943 holding.
  • Jones Financial Companies first reported a position in Teladoc Health in Q4 2022 and has held it in 11 quarters since.
  • Jones Financial Companies's Teladoc Health position peaked at $107K in Q4 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.